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ABSTRACT
Objective: To examine the prevalence of white matter hyperintensities (WMHs) in patients with trau-
matic brain injury (TBI) as compared to healthy controls, and to investigate whether there is an
association between WMH lesion burden and performance on neuropsychological tests in patients
with TBI.
Methods: A total of 59 patients with TBI and 27 age- and gender-matched healthy controls underwent
thorough neuropsychological testing and magnetic resonance imaging. The quantification of WMH
lesions was performed using the fully automated Lesion Segmentation Tool.
Results: WMH lesions were more common in patients with TBI than in healthy controls (p = .032), and
increased with higher TBI severity (p = .025). Linear regressions showed that WMH lesions in patients
with TBI were not related to performance on any neuropsychological tests (p > .05 for all). However,
a negative relationship between number of WMH lesions in patients with TBI and self-assessed fatigue
was found (r = – 0.33, p = .026).
Conclusion: WMH lesions are more common in patients with TBI than in healthy controls, and WMH
lesions burden increases with TBI severity. These lesions could not explain decreased cognitive function-
ing in patients with TBI but did relate to decreased self-assessment of fatigue after TBI.
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White matter hyperintensities (WMH) are lesions in white
matter, detectable with fluid-attenuated inversion recovery
(FLAIR) imaging during magnetic resonance imaging (MRI)
examinations. WMHs are common in normal aging(1), and
increased WMH lesion burden is often seen in patients
affected by various disorders to the brain, such as stroke(2),
diabetes mellitus(3), schizophrenia(4), multiple sclerosis(5),
dementia(6), and traumatic brain injury (TBI) (7–10). In
TBI, the mechanical forces applied to the brain may cause
microbleeds, shearing and/or degraded axon integrity in cere-
bral white matter. These injuries appear as white hyperintense
areas in the FLAIR image. Thus, WMHs are more common in
patients with TBI than in the general population (9,10).
Studies have also indicated that WMHs lesion burden after
TBI is related to both injury severity (8,9,11), and outcome
(8,11–13).
WMHs could also be a factor explaining the reduced cog-
nitive function after a TBI. However, only a few studies have
examined the relationship between WMHs and cognition or
self-experienced symptoms, with conflicting results (14–16).
One explanation for these diverse results may be unreliable
quantification of WMH lesions. Although visual inspection
using scales such as Fazekas (17) and Scheltens (18) show
satisfying intra- and interobserver reliability, automated
WMH lesion tools are more precise, more reliable and rapid
when quantifying WMH lesions(19).
The first objective of this study was to compare patients
with TBI to age- and gender-matched healthy controls regard-
ing frequency and volume of WMH lesions, as determined by
the fully automated Lesion Segmentation Tool (LST; www.
statistical-modeling.de/lst.html). The second objective was to
determine the relation between the frequency and volume of
WMHs and TBI severity. The final objective was to investigate
the relationship among TBI-related WMHs, neuropsychologi-
cal performance, and fatigue. We included neuropsychological
measures of several different cognitive functions. The first
step was to examine if there were differences between healthy
controls and patients with TBI in these measures. In a second
step, we probed whether WMHs moderated these differences.
Materials and methods
Participants
All patients with TBI were recruited from a previous clinical
trial(20), where a detailed description of the recruitment pro-
cess and inclusion and exclusion criteria have been extensively
described. Inclusion criteria were TBI > 1 year previously, age
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18 to 65 years, and moderate disability or better recovery
according to the Extended Glasgow Outcome Scale(21).
Further, all patients suffered from self-experienced fatigue,
defined as a Fatigue Severity Scale (22) score >36. In short,
exclusion criteria were other psychiatric or neurologic disor-
ders, substance abuse, liver-, heart-, kidney- or neoplastic
disease, and history of epileptic seizures. Reported TBI sever-
ity was based on length of loss of consciousness at time of
injury according to the VA/DOD clinical practice guideline
(23). This data was gathered either by patient self-report or,
when available, confirmed in medical records. A total of 60
patients underwent MRI examination, but one ended the
examination before any FLAIR images were acquired and
was therefore not included in the analysis. Of these 59
patients, 55 returned for the follow up MRI scan. In all
analyses, except for the test–retest reliability analysis, the
first scan of all 59 patients was used.
Healthy controls were recruited among family and friends
of patients with an interest to participate in the study. The
recruitment process of these has previously been extensively
described(24). In short, the healthy participants had the same
inclusion and exclusion criteria as patients, with the addition
of never having suffered a concussion or more severe head
injury. A total of 30 healthy controls went through all exam-
inations. Three of these were excluded due to incidental find-
ings during the MRI examination, or scoring above cutoffs for
clinical conditions on self-assessment scales. Thus, a total of
27 healthy controls were included in the analysis.
Demographical characteristics of the patients with TBI and
the healthy controls can be seen in Table 1. There were no
differences between groups in age or distribution in gender.
However, there were significant differences in education (p =
.03) and employment status (p< .001), where healthy controls
had higher education, and were working/studying at a higher
degree.
Neuropsychological measures
All participants went through extensive neuropsychological
testing with the following tests in the following order: Rey
Auditory Verbal Learning Test (25) (measuring mainly
episodic learning); Coding (processing speed) from Wechsler
Adult Intelligence Scale, 4th edition (WAIS-IV (26)); Digit
Span (working memory) from Wechsler Memory Scale, 3rd
edition (WMS-III (27)); Trail Making Test (attention and
executive functions) from Delis-Kaplan Executive Functions
System (D-KEFS (28)); Rey Auditory Verbal Learning Test
Delayed Recall (episodic memory recall); Paced Auditory
Serial Addition Test (29) (attention and processing speed);
Symbol Search (processing speed) from WAIS-IV; Block Span
(working memory) from WMS-III; Color-Word Interference
Test (executive functions) from D-KEFS; and Verbal Fluency
(executive functions) from D-KEFS. All participants also com-
pleted two self-assessment scales of fatigue in everyday life,
the Fatigue Severity Scale (FSS (22)) and the Mental Fatigue
Scale (MFS (30)).
Procedure
This study was approved by the regional ethics board in Umeå
University, Sweden and was performed following the princi-
ples of the Declaration of Helsinki. At start of the study, all
participants read and signed informed consent before begin-
ning examinations. All patients with TBI performed the
assessments on two occasions. The neuropsychological tests
and self-assessments of fatigue were performed on 1 day, and
the MRI imaging procedure, including fMRI with task(31),
were performed 1 week later. Healthy controls underwent all
examinations in 1 day, starting with the MRI imaging proce-
dure, followed by a 30-min break and continuing with neu-
ropsychological tests and self-assessment scales. Patients with
TBI also underwent an identical MRI imaging procedure 28
days later, after completing a clinical trial (20) that should not
affect the structure of the brain. This latter scan was used in
the reliability analysis only.
Magnetic resonance imaging procedure
A 3T Discovery MR 750 General Electric scanner (General
Electric Company, Chicago, IL, USA) were used on all scan-
ning occasions. The fMRI session with the fMRI task was
performed first, followed by anatomical imaging acquisition.
T1-weighted images were collected using a 3D fast spoiled
gradient-echo sequence with 176 slices, and a slice thickness
of 1 mm. Repetition time 8.2 ms, Echo time = 3.2 ms, flip
angle = 12° and field of view = 25 × 25 cm. Fluid-attenuated
inversion recovery (FLAIR) images were acquired using a 2D
T2 FLAIR sequence in 48 slices with 3 mm thickness;
Repetition Time: 8000 ms, Echo Time: 120 ms, field of view:
24 × 24 cm.
Statistical analyses
WMH lesions were segmented in SPM12 with the Lesion
Segmentation Tool (LST) toolbox version 2.0.15 (www.statis
tical-modeling.de/lst.html) using the lesion growth algorithm
(32). This algorithm first segments T1images into white mat-
ter, gray matter and cerebrospinal fluid, and subsequently
combines this with coregistered FLAIR intensities to obtain
hyperintense lesions in white matter. The prechosen initial
threshold for the created lesions map was set to .3, as default
Table 1. Demographics.
Patients with
TBI (n = 59)
Healthy
Controls
(n = 27) Group difference
M SD M SD p-value
Age 42.20 13.33 38,15 12,29 .184
Years since injury 8.64 7.27






- Primary School 7 0
- Vocational School 8 2
- Upper secondary school 27 9
- University 17 16
Employment status <.001
- Full time work/studies 18 24
- Part time work/studies 14 3
- Sick leave/retired 27 0
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and recommended by the developers(33). The result from this
analysis is a lesion probability map. Due to skewness in the
distribution of both WMH lesion volume and number of
WMH lesions, all analyses with these as dependent variables
used non-parametric tests, Mann–Whitney U for two groups
and Kruskal–Wallis for three groups or more. Spearman’s
tests were used for correlations to test for test-retest-
reliability of the scanning and analysis procedure between
two MRI scans in patients. The correlation between the two
scanning occasions in patients with TBI was very strong both
regarding number of WMH lesions (r = 0.94, p < .001) and
WMH lesion volume (r = 0.96, p < .001), indicating high test–
retest reliability. To investigate relationships between TBI-
related WMHs and neuropsychological measures, linear
regression analysis were performed. In the first, unadjusted
analysis, the neuropsychological measure of interest was used
as the dependent variable and group (TBI or healthy control)
was used as predictor. In the next step, WMH lesion volume
or number of WMH lesions were included as a covariate. The
last, fully adjusted model, included group (TBI or control),
age, education level, and WMH lesion volume or number of
WMH lesions. Linear regressions were also performed in the
TBI group only, with WMH lesions as explanatory variable,
with age and education as covariate, and neuropsychological
measures and self-assessments of fatigue as dependents.
Results
At least one WMH lesion was present in 59.3% of healthy
controls and 81.4% of patients with TBI. Patients with TBI had
a higher degree of number of WMH lesions (p = .032) and total
WMH lesion volume (p = .025; Figure 1).When healthy controls
were compared with the different TBI severity subgroups it was
found that they differed from both the moderate (p = .049 for
number of WMH lesions and p = .032 for lesion volume) and
severe (p = .009 for number of WMH lesions and p = .005 for
lesion volume) TBI groups, but not from the mild TBI group.
Comparison of the three groups of patients with TBI showed
a significant group difference for both number ofWMH lesions (p
= .043) and lesion volume (p = .011). Follow-up Mann–Whitney
U tests revealed that patients with mild TBI had a lower number
of WMH lesions (p = .017) and lesion volume (p = .006) than
patients with severe TBI. There was also a trend toward patients
with mild TBI having lower degree of WMH lesion volume than
patients with moderate TBI (p = .079). No significant differences
between patients with moderate versus severe TBI were observed
when it comes toWMH lesions (all p’s > .10), likely due to the low
number of observations (cf., Figure 1).
Relations among white matter hyperintensities and
neuropsychological data
Linear regression analyses (Table 2) revealed significant differ-
ences between healthy controls and patients with TBI on all
measures of fatigue and neuropsychological tests (all p’s < 0.05),
except for PASAT, Block span and the Verbal Fluency tests.
Adjusting for WMH lesion volume or number of WMH lesions,
education and age did not change the associations regarding self-
assessment of fatigue. However, for most neuropsychological test,
the differences between healthy controls and patients with TBI
were no longer significant. Only the tests Coding, Symbol Search
and Color-Word Interference Test: Inhibition/Switching showed
significant differences between groups in the fully adjusted model.
In the fully adjusted models, WMH lesion volume or number of
WMH lesions was not related to performance in any neuropsy-
chological test. In contrast, number of lesions was in the fully
adjusted model negatively related to self-assessment of fatigue on
the MFS (p = .010), indicating lower self-assessment of fatigue
with higher lesion load.
To further investigate the contribution of TBI-related
WMH lesions to neuropsychological measures, linear regres-
sions were performed within the TBI group only. In the fully
adjusted models with lesion volume, age, and education,
WMH lesions were not significantly related to any outcome.
However, number of lesions were significantly negatively
related to the MFS in the fully adjusted model (r = – 0.35,
p = .024), indicating less fatigue with increased lesion load.
Discussion
In the present study, we found a higher degree of both
number and volume of WMH lesions in patients with TBI
than in age- and gender-matched healthy controls. Further,
there was a steady increase in both number of WMH lesions
and volume with increasing TBI severity. Thus, patients with
mild TBI showed significantly lower degree of WMH lesions
than patients with moderate and severe traumatic brain
injury. In summary, these data confirm results from previous
studies (8,9,11) that WMH lesion load is related to injury
severity. For the first time, this has been shown using the
automated lesion segmentation tool LST.
The moderate and severe TBI groups differed from healthy
controls in both WMH lesion variables, but the mild TBI group
did not. This is in support of previous evidence that patients with
Figure 1. Mean number of white matter hyperintensity (WMH) lesions and total
WMH lesion volume in healthy controls and patients with traumatic brain injury
(TBI). The bars on the left represent all healthy controls and all patients with TBI,
while the bars to the right represent patients with TBI divided after TBI severity
(Mild, Moderate, Severe). Error bars indicate standard error of mean. Stars
indicate significant differences: *p < .05; **p < .01; ☥p = .079.
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mild TBI do not always display structural changes after MRI(34),
in this case, white matter lesions as indicated by WMH on the
FLAIR sequence. Nevertheless, the association between more
severe TBIs and WMH is of clinical interest since both TBIs
(35–38) and WMHs (6,39) have been strongly associated with
the risk of dementia, and in particular vascular dementia (37,38).
One hypothesis to explain the associations between TBI and
dementia is that a TBI reduces the cognitive reserve(40).
A purpose of the present study was therefore to evaluate if the
association between TBI and the different measures of cognitive
function was influenced by the degree of WMH. However, the
results showed that the lower cognitive function in individuals
with a previous TBI was largely unaffected by WMH lesion
burden. Furthermore, no neuropsychological test result was
related to WMH lesions in the age and education-adjusted
models in the TBI-group. The results from these analyses indi-
cate that TBI-related WMH lesions are not connected to perfor-
mance on several neuropsychological tests, and therefore it is
still unclear whether WMH lesions after TBI is a contributing
factor to the increased risk of dementia.
Previous studies have indicated associations between different
measures of cognitive performance and WMH lesions in patients
with TBI, such as episodic memory(14), working memory(15),
andmental speed, attention and executive functions(16), although
results between studies have been contradictory. Our study
included neuropsychological tests measuring all of these func-
tions, in some cases even the same tests as previous studies, but
did not find any relationships with WMH lesions. One major
reason for these diverse results may be the quantification of
WMHs by manual analysis in previous studies. The lack of asso-
ciation in our study may also relate to a lesion load that was too
small to be detected in the different cognitive test used. Most of
the TBIs were defined as mild, and it has been suggested that
WMH lesions must reach a specific threshold to affect cognition
(41), since connectivitymight be an important factor in explaining
cognitive dysfunction and fatigability after TBI(42).
Although TBI-related WMH lesions were not related to
neuropsychological test results, one significant relationship
between number of lesions and self-assessed fatigue was
found. This relationship was however negative, meaning that
an increased number of WMH lesions was related to less
fatigue. In contrast, one might believe that increased lesion
load within the brain would cause more fatigue. This last
notion has however been difficult to prove. Most studies
have actually found that the severity of head injury is not
related to self-experienced fatigue (43–45). Assessing fatigue
after TBI is difficult, and although there are more than 30 self-
assessment scales of fatigue, there is no “gold standard” for
assessing fatigue after TBI(46). In the present study, we used
two commonly used measures, the Fatigue Severity Scale (22)
and the Mental Fatigue Scale, (30) which both have shown
acceptable psychometric properties. Still, with other measures
of fatigue, the result might have been different. It should also
be noted that the relationship between number of WMH
lesions and self-assessment of fatigue was rather weak, and
the results may possibly be an effect of multiple comparisons.
Another explanation for the negative relationship might be
that patients with more severe injuries may have difficulties
with self-awareness, making the self-assessments of fatigue
less valid. Future research examining the relationship between
WMH lesions and self-experienced fatigue should thus
include and adjust for measures of self-awareness.
More than 20% of patients with mild TBI did not have any
WMH lesions. Still, they suffered from fatigue and other neu-
ropsychological impairments one or several years after a mild
TBI, which usually resolves within months from injury(47).
However, studies do show that there are a few cases of mild
TBI that do not recover, but instead experience persisting or
chronic symptoms (48,49), even though many do not have any
objectively verified injuries in radiological examinations(50).
Some have even suggested that persisting symptoms after mild
TBI may not be related to the brain injury per se, but instead to
other factors(51). It is of course reasonable to expect this “mis-
erable minority”(52) to stay in contact with neurorehabilitation
centers, thus being possible to include in the present study. It has
also been stated that mild TBIs, especially concussions, do not
cause structural damage within the brain, but instead affects the
functionality of the brain (50). Thus, structural imaging of the
brain may not always be suitable in the detection of subtle
cognitive impairment or fatigue after TBI. Our study does not
contribute to the understanding of why these patients have
symptoms but suggests that WMH lesions cannot explain these
Table 2. Results from linear regressions comparing healthy controls and patients with TBI.
Unadjusted Lesion Volume Lesion Volume, Age, Education Nr of Lesions Nr of Lesions, Age, Education
Fatigue Severity Scale 23.94*** 24.13*** 23.95*** 24.30*** 24.00***
Mental Fatigue Scale 14.4*** 14.50*** 14.27*** 14.72*** 14.37***^’
Rey Auditory Verbal Learning Test: learning −5.89* −5.17*^ −2.78ʹ† −5.43* −3.07ʹ’††
Rey Auditory Verbal Learning Test: delayed recall −1.85* −1.58*^^ −0.98’ −1.65* −1.07ʹ’†
Coding −23.62*** −23.13*** −17.58***’’††† −22.55*** −17.73***’’†††
Digit span total −2.00* −1.87* −1.17† −1.80* −1.19†
Trail-Making Test: number sequencing 9.22* 8.41* 4.86ʹ† 8.34* 5.10††
Trail-Making Test: number–letter switching 44.66** 42.34* 28.84ʹ† 40.91* 29.51ʹ†
Paced Auditory Serial Addition Test −3.07 2.27^^ −0.48ʹ†† −2.65 −0.83ʹ’††
Symbol search −12.74*** −12.19***^ −10.43***’’† −11.99***^ −10.53***’’†
Block span total −0.60 −0.56 0.12ʹ’† −0.46 0.10ʹ’†
Color–Word Interference Test: inhibition 13.66* 13.68* 9.88 13.56* 10.11’
Color–Word Interference Test: inhibition/switching 28.16*** 26.94*** 24.21**’ 26.77*** 24.57**’
Verbal Fluency: word fluency −3.76 −3.46 −1.66 −4.30 −2.05†
Verbal Fluency: category fluency −5.38 −4.88 −3.12† −5.80* −3.44†
Verbal Fluency: category switching −1.58* −1.56 −0.99† −1.60* −1.04†
Note: Values indicate the unstandardized coefficient (difference) between healthy controls and patients with TBI. Symbols denote significant contribution of that
variable to the regression. *Healthy Controls vs TBI; ^WMH lesion; ‘Age; †Education. Number of symbols indicate p-value: 1 symbol: p< .05; 2 symbols: p < .01; 3
symbols; p < .001.
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symptoms. More studies are needed to investigate the mechan-
isms behind persisting symptoms in this patient group.
Limitations
This study has several limitations. First and foremost, the sample
is small, especially in the moderate-severe TBI groups, affecting
power in all analyses, which can be a contributing factor to the
negative results regarding relationships between TBI-related
WMHs and neuropsychological performance. Further, the sam-
ple is rather heterogenic, both when it comes to TBI severity and
time since injury. All patients had favorable outcomes (i.e. GOSE
moderate or better recovery), making generalization to patients
with less favorable outcome limited. It is also important to note
that all patients in the current study were more than one year
from injury (mean of more than 8 years). These patients are
suffering from persistent symptoms after their brain injury,
which means that they are possibly different from patients
recovering more quickly, both regarding premorbid (53) and
injury-related (48) factors. Thus, the results only generalize to
patients in the chronic phase of traumatic brain injury.
Conclusions
This study shows that WMH lesions are related to suffering
a TBI, and that there is an increased WMH lesion load with
increased TBI severity. However, in the present study, these
TBI-related WMH lesions were not related to performance on
neuropsychological tests but number of WMH lesions was
negatively related to self-assessment of fatigue.
Acknowledgments
The authors would like to thank Erika Burkvist, Erik Edin, Gustav
Gezelius, and Mikael Stiernstedt for assistance in data collection.
Disclosure Statement
This study was funded through a regional agreement between Umeå
University and Västerbotten County Council on cooperation in the
field of Medicine, Odontology, and Health, and Torsten & Ragnar
Söderberg’s Foundation. The authors report no conflict of interest.
Funding
This work was supported by the Torsten & Ragnar Söderberg’s
Foundation; and A regional agreement between Umeå University and





1. Pekala JS, Mamourian AC, Wishart HA, Hickey WF, Raque JD.
Focal lesion in the splenium of the corpus callosum on FLAIR MR
images: a common finding with aging and after brain radiation
therapy. AJNR Am J Neuroradiol. 2003;24(5):855–61.
2. Grysiewicz R, Gorelick PB.Key neuroanatomical structures for
post-stroke cognitive impairment. Curr Neurol Neurosci Rep.
2012;12(6):703–08. doi:10.1007/s11910-012-0315-2.
3. Tamura Y, Araki A.Diabetes mellitus and white matter
hyperintensity. Geriatr Gerontol Int. 2015;15(Suppl 1):34–42.
doi:10.1111/ggi.12666.
4. Miyaoka T, Yasukawa R,Mihara T,Mizuno S, Yasuda H, Sukegawa T,
Hayashida M, Inagaki T, Horiguchi J.Fluid-attenuated inversion-
recovery MR imaging in schizophrenia-associated with idiopathic
unconjugated hyperbilirubinemia (Gilbert’s syndrome). Eur
Psychiatry. 2005;20(4):327–31. doi:10.1016/j.eurpsy.2004.12.012.
5. Bakshi R, Minagar A, Jaisani Z, Wolinsky JS.Imaging of multiple
sclerosis: role in neurotherapeutics. NeuroRx. 2005;2(2):277–303.
6. Debette S, Markus HS. The clinical importance of white matter
hyperintensities on brain magnetic resonance imaging: systematic
review and meta-analysis. BMJ. 2010;341:c3666.
7. Bigler ED, Abildskov TJ, Goodrich-Hunsaker NJ, Black G,
Christensen ZP, Huff T, Wood DM, Hesselink JR, Wilde EA,
Max JE.Structural neuroimaging findings in mild traumatic
brain injury. Sports Med Arthrosc Rev. 2016;24(3):e42–52.
8. Ding K, Marquez de la Plata C, Wang JY, Mumphrey M, Moore C,
Harper C, Madden CJ, McColl R, Whittemore A, Devous MD, et al.
Cerebral atrophy after traumatic white matter injury: correlation with
acute neuroimaging and outcome. J Neurotrauma. 2008;25
(12):1433–40.
9. Riedy G, Senseney JS, Liu W, Ollinger J, Sham E, Krapiva P, Patel JB,
SmithA, Yeh PH,Graner J, et al. Findings from structuralMR imaging
in military traumatic brain injury. Radiology 2016;279:207–15.
10. Trifan G, Gattu R, Haacke EM, Kou Z, Benson RR. MR imaging
findings in mild traumatic brain injury with persistent neurological
impairment. Magn Reson Imaging. 2017;37:243–51. doi:10.1016/j.
mri.2016.12.009.
11. Pierallini A, Pantano P, Fantozzi LM, Bonamini M, Vichi R,
Zylberman R, Pisarri F, Colonnese C, Bozzao L.Correlation between
MRI findings and long-term outcome in patients with severe brain
trauma. Neuroradiology. 2000;42(12):860–67. doi:10.1007/
s002340000447.
12. Moen KG, Brezova V, Skandsen T, Haberg AK, Folvik M, Vik A.
Traumatic axonal injury: the prognostic value of lesion load in corpus
callosum, brain stem, and thalamus in different magnetic resonance
imaging sequences. J Neurotrauma. 2014;31(17):1486–96.
doi:10.1089/neu.2013.3258.
13. Marquez de la Plata C, Ardelean A, Koovakkattu D, Srinivasan P,
Miller A, Phuong V, Harper C, Moore C, Whittemore A,
Madden C, et al. Magnetic resonance imaging of diffuse axonal
injury: quantitative assessment of white matter lesion volume.
J Neurotrauma. 2007;24(4):591–98. doi:10.1089/neu.2006.0214.
14. Clark AL, Sorg SF, Schiehser DM, Luc N, Bondi MW,
Sanderson M, Werhane ML, Delano-Wood L.Deep white matter
hyperintensities affect verbal memory independent of PTSD
symptoms in veterans with mild traumatic brain injury. Brain
Inj. 2016;30(7):864–71. doi:10.3109/02699052.2016.1144894.
15. Tate DF, Gusman M, Kini J, Reid M, Velez CS, Drennon AM,
Cooper DB, Kennedy JE, Bowles AO, Bigler ED, et al.
Susceptibility weighted imaging and white matter abnormality
findings in service members with persistent cognitive symptoms
following mild traumatic brain injury. Mil Med. 2017;182(3):
e1651–e1658. doi:10.7205/MILMED-D-16-00132.
16. Spitz G, Maller JJ, Ng A, O’Sullivan R, Ferris NJ, Ponsford JL.
Detecting lesions after traumatic brain injury using susceptibility
weighted imaging: a comparison with fluid-attenuated inversion
recovery and correlation with clinical outcome. J Neurotrauma.
2013;30(24):2038–50. doi:10.1089/neu.2013.3021.
17. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA.MR
signal abnormalities at 1.5 T in Alzheimer’s dementia and normal
aging. AJR Am J Roentgenol. 1987;149(2):351–56. doi:10.2214/
ajr.149.2.351.
BRAIN INJURY 419
18. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P,
Steinling M, Valk J.A semiquantative rating scale for the assessment
of signal hyperintensities on magnetic resonance imaging. J Neurol
Sci. 1993;114(1):7–12. doi:10.1016/0022-510X(93)90041-V.
19. Prins ND, Scheltens P.White matter hyperintensities, cognitive
impairment and dementia: an update. Nat Rev Neurol. 2015;11
(3):157–65. doi:10.1038/nrneurol.2015.10.
20. Berginstrom N, Nordstrom P, Schuit R, Nordstrom A.The effects of
(-)-OSU6162 on chronic fatigue in patients with traumatic brain
injury: a randomized controlled trial. J Head Trauma Rehabil.
2017;32(2):E46–E54. doi:10.1097/HTR.0000000000000236.
21. Teasdale GM, Pettigrew LE, Wilson JT, Murray G, Jennett B.
Analyzing outcome of treatment of severe head injury: a review
and update on advancing the use of the glasgow outcome scale.
J Neurotrauma. 1998;15(8):587–97. doi:10.1089/neu.1998.15.587.
22. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD.The fatigue
severity scale. Application to patients with multiple sclerosis and
systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–23.
doi:10.1001/archneur.1989.00520460115022.
23. Management of Concussion-mild Traumatic Brain Injury
Working Group. VA/DoD clinical practice guideline for the man-
agement of concussion-mild traumatic brain injury (Version 2.0).
Washington, D.C.: Department of Vetarans Affairs; Department
of Defense; 2016.
24. Nordström P, Ekman U, Eriksson J, Andersson M, Nyberg
LNordström A. Using functional magnetic resonance imaging to
detect chronic fatigue in patients with previous traumatic brain
injury: changes linked to altered striato-thalamic-cortical func-
tioning. Journal Of Head Trauma Rehabilitation. 2018;33:266-274.
25. Rey A. L’examen clinique en psychologie. Paris: Presses
Universitaire de France; 1964.
26. Wechsler D. Wechsler adult intelligence scale. 4th ed. San
Antonio: Pearson; 2008.
27. Wechsler D. Wechsler Memory Scale. 3rd ed. San Antonio:
Psychological Corporation; 1997.
28. Delis DC, Kaplan E, Kramer JH. D-KEFS - delis kaplan executive
functions system – technical manual. San Antonio: Pearson; 2001.
29. Gronwall DM.Paced auditory serial-addition task: a measure of
recovery from concussion. Percept Mot Skills. 1977;44(2):367–73.
doi:10.2466/pms.1977.44.2.367.
30. Johansson B, Starmark A, Berglund P, Rodholm M, Ronnback L.A
self-assessment questionnaire for mental fatigue and related
symptoms after neurological disorders and injuries. Brain Inj.
2010;24(1):2–12. doi:10.3109/02699050903452961.
31. Berginstrom N, Nordstrom P, Ekman U, Eriksson J,
Andersson M, Nyberg L, Nordström A.Using functional magnetic
resonance imaging to detect chronic fatigue in patients with pre-
vious traumatic brain injury: changes linked to altered
striato-thalamic-cortical functioning. J Head Trauma Rehabil.
2018;33(4):266–74. doi:10.1097/HTR.0000000000000340.
32. Schmidt P, Gaser C, Arsic M, Buck D, Förschler A, Berthele A,
Hoshi M, Ilg R, Schmid VJ, Zimmer C, et al.An automated tool
for detection of FLAIR-hyperintense white-matter lesions in mul-
tiple sclerosis. Neuroimage. 2012;59(4):3774–83. doi:10.1016/j.
neuroimage.2011.11.032.
33. Schmidt P, Wink L. LST: A lesion segmentation tool for SPM.
Manual/documentation for version 2.0.15. https://www.applied-
statistics.de/LST_documentation.pdf, 2017.
34. McCrory P, Meeuwisse WH, Aubry M, Cantu RC, Dvořák J,
Echemendia RJ, Engebretsen L, Johnston KM, Kutcher JS, Raftery M,
et al. Consensus statement on concussion in sport: the 4th interna-
tional conference on concussion in sport, Zurich, November 2012.
J Athl Train. 2013;48(4):554–75. doi:10.4085/1062-6050-48.4.05.
35. Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A.
Head injury as a risk factor for Alzheimer’s disease: the evidence
10 years on; a partial replication. J Neurol Neurosurg Psychiatry.
2003;74(7):857–62. doi:10.1136/jnnp.74.7.857.
36. Lee YK,Hou SW, Lee CC,HsuCY,Huang YS, Su YC.Increased risk of
dementia in patients with mild traumatic brain injury: a nationwide
cohort study. PLoS One. 2013;8(5):e62422. doi:10.1371/journal.
pone.0062422.
37. Nordstrom P, Michaelsson K, Gustafson Y, Nordstrom A.Traumatic
brain injury and young onset dementia: a nationwide cohort study.
Ann Neurol. 2014;75(3):374–81. doi:10.1002/ana.24101.
38. Nordstrom A, Nordstrom P.Traumatic brain injury and the risk
of dementia diagnosis: A nationwide cohort study. PLoS Med.
2018;15(1):e1002496. doi:10.1371/journal.pmed.1002496.
39. Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB,
Griffith EY, Provenzano FA, Schupf N, Manly JJ, Stern Y, et al.
Reconsidering harbingers of dementia: progression of parietal
lobe white matter hyperintensities predicts Alzheimer’s disease
incidence. Neurobiol Aging. 2015;36(1):27–32. doi:10.1016/j.
neurobiolaging.2014.07.019.
40. Stern Y.Cognitive reserve in ageing and Alzheimer’s disease. Lancet
Neurol. 2012;11(11):1006–12. doi:10.1016/S1474-4422(12)70191-6.
41. DeCarli C, Murphy DG, Tranh M, Grady CL, Haxby JV, Gillette JA,
Salerno JA, Gonzales-Aviles A, Horwitz B, Rapoport SI, et al. The
effect of white matter hyperintensity volume on brain structure, cog-
nitive performance, and cerebral metabolism of glucose in 51 healthy
adults. Neurology. 1995;45(11):2077–84. doi:10.1212/
WNL.45.11.2077.
42. Schonberger M, Reutens D, Beare R, O’Sullivan R,
Rajaratnam SMW, Ponsford J.Brain lesion correlates of fatigue
in individuals with traumatic brain injury. Neuropsychol Rehabil.
2017;27(7):1056–70. doi:10.1080/09602011.2016.1154875.
43. Belmont A, Agar N, Hugeron C, Gallais B, Azouvi P.Fatigue and
traumatic brain injury. Ann Readapt Med Phys. 2006;49(6):283–-
288, 370–284. doi:10.1016/j.annrmp.2006.04.017.
44. Ziino C, Ponsford J.Measurement and prediction of subjective
fatigue following traumatic brain injury. J Int Neuropsychol Soc.
2005;11(4):416–25. doi:10.1017/S1355617705050472.
45. Bushnik T, Englander J, Wright J.The experience of fatigue in the first
2 years after moderate-to-severe traumatic brain injury: a preliminary
report. J Head Trauma Rehabil. 2008;23(1):17–24. doi:10.1097/01.
HTR.0000308717.80590.22.
46. Cantor JB, Gordon W, Gumber S.What is post TBI fatigue?
NeuroRehabilitation. 2013;32(4):875–83. doi:10.3233/NRE-130912.
47. Carroll LJ, Cassidy JD, Peloso PM, Borg J, von Holst H, Holm L,
Paniak C, Pépin M. WHO collaborating centre task force on mild
traumatic brain injury. Prognosis for mild traumatic brain injury:
results of the WHO collaborating centre task force on mild trau-
matic brain injury. J Rehabil Med. 2004;36:84–105. doi:10.1080/
16501960410023859.
48. Klein M, Houx PJ, Jolles J.Long-term persisting cognitive sequelae
of traumatic brain injury and the effect of age. J Nerv Ment Dis.
1996;184(8):459–67. doi:10.1097/00005053-199608000-00002.
49. Stalnacke BM, Elgh E, Sojka P.One-year follow-up of mild trau-
matic brain injury: cognition, disability and life satisfaction of
patients seeking consultation. J Rehabil Med. 2007;39(5):405–11.
doi:10.2340/16501977-0057.
50. McCrory P, Meeuwisse W, Dvorak J, Aubry M, Bailes J, Broglio S,
Cantu RC, Cassidy D, Echemendia RJ, Castellani RJ, et al.
Consensus statement on concussion in sport-the 5(th) interna-
tional conference on concussion in sport held in Berlin, October
2016. Br J Sports Med 2017;51:838–47.
51. Cassidy JD, Cancelliere C, Carroll LJ, Côté P, Hincapié CA,
Holm LW, Hartvigsen J, Donovan J, Nygren-de Boussard C,
Kristman VL, et al.Systematic review of self-reported prognosis
in adults after mild traumatic brain injury: results of the interna-
tional collaboration on mild traumatic brain injury prognosis.
Arch Phys Med Rehabil. 2014;95(3 Suppl):S132–151.
52. Ruff RM, Camenzuli L, Mueller J.Miserable minority: emotional
risk factors that influence the outcome of a mild traumatic brain
injury. Brain Inj. 1996;10(8):551–65.
53. Oldenburg C, Lundin A, Edman G, Nygren-de Boussard C,
Bartfai A.Cognitive reserve and persistent post-concussion symp-
toms–A prospective mild traumatic brain injury (mTBI) cohort
study. Brain Inj. 2016;30(2):146–55.
420 N. BERGINSTRÖM ET AL.
